3i Group plc: non-executive Director appointment
3i Group plc announces the appointment of Alexandra Schaapveld as a non-executive Director with effect from 1 January 2020.
Alexandra Schaapveld is currently a member of the supervisory boards of Societe Generale S.A., Vallourec S.A. and The Netherlands Development Finance Company. She is also a non-executive director of Bumi Armada Berhad in Malaysia. She was previously on the boards of Holland Casino, VU University and VU Medical Center, Stage Entertainment and Duin & Kruidberg.
Prior to that Alexandra was Head of Global Banking and Markets in Western Europe for Royal Bank of Scotland and had previously worked for many years for ABN AMRO.
Simon Thompson, 3i Chairman, said: "We are very pleased to announce Alexandra's appointment to 3i's Board. She brings extensive financial services expertise in a number of important markets for 3i and significant board experience in a variety of sectors."
Alexandra commented: "I am very pleased to be joining 3i as the company continues to focus on successfully executing its strategic plan. 3i has a strong management team, a strong institutional franchise and is well placed to continue to generate value for its shareholders."
There are no further matters to be disclosed in accordance with paragraph 9.6.13R of the UKLA's Listing Rules.
For further information, contact:
Kathryn van der Kroft 020 7975 3021
Silvia Santoro 020 7975 3258
Investor Relations Director
Notes to Editors:
3i is a leading international investment manager focused on mid-market private equity and infrastructure. Its core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact firstname.lastname@example.org or visit www.rns.com.